Purchase Order W81K0224P0069
Award Date
8/30/24
Potential Completion Date
9/30/24
Potential Value
$62K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Department of the Army Medical Command to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents. The $144,074.38 contract is for Illumina RNA prep with enrichment supplies to support the MiSeq system used at the Tripler Army Medical Center in Hawaii. The award was made on a sole-source basis without a set-aside, citing Illumina as the only responsible source for the proprietary sequencing technology....
The Department of the Army Medical Command awarded a $247,627.76 firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturing organization, for Illumina RNA Prep with Enrichment products and services. The contract does not have a set-aside designation. This award was made without full and open competition under the sole-source authority of FAR 13.106-1(b)(1)(i) based on Illumina's proprietary sequencing technology and status as the sole manufacturer. Illumina has a history of...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
This firm fixed price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The $119,937.50 contract is for the procurement of replacement laboratory equipment, specifically next-generation sequencing systems and associated consumables, to support the agency's biodefense research and diagnostics efforts. Illumina has previously been awarded prime contracts and subcontracts across various federal...
This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
This is a firm fixed price delivery order contract valued at $242,110.64 awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina reagents to support the agency's sequencing and genomic analysis needs, without any set-aside designation. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing systems and related products and...
This is a firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $95,931.00, is for the delivery of a MiSeq System, a DNA sequencing instrument used for genomic research and diagnostics. While Illumina has previously received prime contract and sub-contract awards from other federal agencies such as the NIH, CDC, USDA, and VA to provide a range of its sequencing...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Illumina, Inc. for next-generation sequencing (NGS) reagents to provide high-resolution human leukocyte antigen (HLA) typing for transplant recipients and donors. The $22,467.76 contract has a completion date of June 12, 2024. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing sequencing systems and related products to support genomic research...
This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $154,828.40 contract is for the purchase of reagents to support MEDCOM's genomic analysis and sequencing capabilities. Illumina has previously received other federal contracts and subcontracts from agencies like the National Institutes of Health, Centers for Disease Control, and Department of Veterans Affairs to provide...